for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Reuters Now

Amgen drug stops heart attack but fails to woo investors

Posted

Amgen proved in a large-scale clinical trial that it's Repatha drug lowers the risk of heart attacks and strokes, but the company's stock still performed poorly on Friday.

Reuters Now

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up